Skip to main content
. 2023 Nov 15;13:19927. doi: 10.1038/s41598-023-43099-6

Figure 8.

Figure 8

This scheme illustrates the proposed role of RAS in the heart of BO-treated mice. BO-treatment induces dual phosphorylation on PKCδ (Tyr-311/Thr-505), leading to CaMKII activation with the increased ROS production via activation of NOX4/XO and the ASK1-p38 MAPK cascade, which mediates the phosphorylation of RyR2 (Ser-2814) and PLB (Thr-17). BO-treatment was previously reported to induce sympathetic nerve activity by our group, leading to the phosphorylation of RyR2 (Ser-2808) and PLB (Ser-16)18. These changes might cause Ca2+ leakage, leading to fibrosis, myocyte apoptosis, oxidative stress and cardiac dysfunction. Solid black lines represent findings in this study and solid gray lines represents finding reported previously18,20. β-AR, β-adrenoreceptor; Gsα, α subunit of Gs; AC5, type 5 adenylyl cyclase; SERCA, sarco/endoplastic reticulumn calcium ATPase; SR, sarcoplasmic reticulumn; RyR2, ryanodine receptor 2.